Article content
Vancouver, British Columbia–(Newsfile Corp. – April 23, 2021) – Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (“Emerald” or “the Company”) has received final approval to list its common shares (the “Common Shares”) on the Canadian Securities Exchange (the “CSE”). The Company will voluntarily delist its Common Shares from the TSX Venture Exchange (the “TSXV”) after market close on Monday, April 26, 2021. The Common Shares will commence trading on the CSE under the same symbol, EMH, at market open Tuesday, April 27, 2021. Trading of the Common Shares in the US will continue unchanged on the OTCQX under the symbol EMHTF.
We apologize, but this video has failed to load.
Emerald Health Therapeutics, Inc. (TSXV:EMH)(OTCQX: EMHTF) has launched a new product line under the SYNC Wellness brand.
The SYNC Tab product line is the second of the company s Defined Dose products, and it expands its offering under its SYNC Wellness brand.
Fast dissolving tablets with 10 mg. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc (EMHTF) - Emerald Health Launches New SYNC Tab Product Line Of Cannabis Dissolvable Tablets benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Emerald Health Therapeutics, Inc. (TSXV:EMH)(OTCQX: EMHTF) has launched a new product line under the SYNC Wellness brand.
The SYNC Tab product line is the second of the company s Defined Dose products, and it expands its offering under its SYNC Wellness brand.
Fast dissolving tablets with 10 mg. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Emerald Health Therapeutics, Inc : Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.